Portrait of Yves Lévy

Born in Morocco · Nationality French — Medical research / Inserm

Yves Lévy

Also known as: Yves Lévy (Inserm)

French immunologist born in Casablanca in 1957; president of Inserm from 2014 to 2018.

Yves Lévy headed Inserm while maintaining a medical research career. His tenure prompted questions over potential conflicts of interest because of his spouse Agnès Buzyn’s positions, and a public dispute over the governance and accreditation of a Marseille research institute. No personal criminal conviction is documented in the sources retained.

Are you concerned? Right of reply

Profile No. 5818 · Updated on 28 October 2026

Portrait of Yves Lévy
5Documented controversies+ 2 background events
7Sources
0Formal charge · all time
0Conviction

I. Documented controversies

Case · 3 documented stages

Potential conflict of interest with the health minister

No legal proceedings
01

2017–2018

Potential conflict of interest with the health minister

No legal proceedings

The appointment of his wife Agnès Buzyn as health minister raised concerns over oversight of Inserm. Revised supervisory arrangements and recusals were introduced.

State of the evidence
Documented by the cited sources; no personal criminal conviction established.
Legal status — source text
No personal criminal proceedings established for this matter.
Attribution
Potential conflict of interest with the health minister

Sources · 2

  1. [1]
  2. [2]
    Gouvernement françaisRenouvellement à la présidence de l’Inserm30 July 2018Official documentHigh reliability

Add to this entry

03

2018

Withdrawal of bid for another Inserm presidency

No legal proceedings

The prospect of another Inserm term revived concerns about potential conflicts of interest involving his wife’s ministerial portfolio. He withdrew his candidacy on 30 July 2018.

State of the evidence
Documented by the cited sources; no personal criminal conviction established.
Legal status — source text
No personal criminal proceedings established for this matter.
Attribution
Withdrawal of bid for another Inserm presidency

Sources · 2

  1. [1]
  2. [2]
    Gouvernement françaisRenouvellement à la présidence de l’Inserm30 July 2018Official documentHigh reliability

Add to this entry

05

2014–2016

Ethics questions involving the National Cancer Institute

No legal proceedings

The spouses’ roles in health organisations raised ethics questions. An INCa ethics committee report described safeguards and noted that ordinary board activity did not itself create a conflict.

State of the evidence
Documented by the cited sources; no personal criminal conviction established.
Legal status — source text
No personal criminal proceedings established for this matter.
Attribution
Ethics questions involving the National Cancer Institute

Sources · 2

  1. [1]
    Institut national du cancerRapport d’activité 2015 du comité de déontologie et d’éthiqueOfficial documentHigh reliability
  2. [2]

Add to this entry

02

2017–2018

Dispute over accreditation of the Marseille research institute

No legal proceedings

A dispute involving Yves Lévy and Didier Raoult concerned IHU governance and non-renewal of Inserm research-unit accreditation in Marseille. Subsequent accusations circulated, but Inserm described collective scientific assessment, and the separate CNRS also withdrew accreditation.

State of the evidence
Documented by the cited sources; no personal criminal conviction established.
Legal status — source text
No personal criminal proceedings established for this matter.
Attribution
Dispute over accreditation of the Marseille research institute

Add to this entry

04

October 2018

Controversy over appointment to the Council of State

No legal proceedings

After leaving Inserm, Lévy was appointed an extraordinary councillor of state. The appointment prompted criticism of positions offered to ministerial relatives, but the cited sources establish no judicial finding of favouritism.

State of the evidence
Documented by the cited sources; no personal criminal conviction established.
Legal status — source text
No personal criminal proceedings established for this matter.
Attribution
Controversy over appointment to the Council of State

Sources · 2

  1. [1]
  2. [2]

Add to this entry

II. Documented background

Documented biographical or institutional milestones (elections, appointments, foundings, acquisitions…). These are not controversies and are not counted as such.

  1. 2014–2018

    Presidency of Inserm

    An immunologist specialising in HIV research among other subjects, Yves Lévy became president of Inserm in 2014 and remained until 2018.

    Sources · 2
    1. Gouvernement français — Renouvellement à la présidence de l’Inserm
    2. Le Monde — Inserm : la reconduction éventuelle d’Yves Lévy embarrasse
  2. 2018

    End of Inserm term and subsequent role

    Lévy left the Inserm presidency in 2018 and subsequently joined the Council of State. This milestone separates the career transition from the criticism of the appointment.

    Sources · 2
    1. Public Sénat — Le président de l’Inserm Yves Lévy nommé conseiller d’État extraordinaire
    2. Gouvernement français — Renouvellement à la présidence de l’Inserm

III. Constellation of documented links

No documented link with another published profile for now.

Two profiles are linked when a documented controversy of one names the other. The link points to that controversy and its sources; it does not indicate a personal relationship.

IV. Has something changed?

A new court decision, a missing source, a mistake? Tell us what should be updated: every request is read by the editorial team.

Support the archive

Controversia checks and updates its profiles independently. Support is optional and has no effect on the content of profiles.

Donate

iPhone and iPad

Install Controversia

  1. Tap Share
  2. then Add to Home Screen

Tap Share, then Add to Home Screen.